Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 47, 2017 - Issue 2
529
Views
13
CrossRef citations to date
0
Altmetric
Molecular Toxicology

The acetaminophen metabolite N-acetyl-p-benzoquinone imine (NAPQI) inhibits glutathione synthetase in vitro; a clue to the mechanism of 5-oxoprolinuric acidosis?

, , , , , , & show all
Pages 164-175 | Received 13 Feb 2016, Accepted 13 Mar 2016, Published online: 18 Apr 2016

References

  • Akai S, Hosomi H, Minami K, et al. (2007). Knock down of gamma-glutamylcysteine synthetase in rat causes acetaminophen-induced hepatotoxicity. J Biol Chem 282:23996–4003
  • Abkur TM, Mohammed W, Ali M, Casserly L. (2014). Acetaminophen-induced anion gap metabolic acidosis secondary to 5-oxoproline: a case report. J Med Case Rep 8:409–13
  • Andersson MP, Uvdal P. (2005). New scale factors for harmonic vibrational frequencies using the B3LYP density functional method with the triple-zeta basis set 6 − 311 + G(d,p). J Phys Chem A 109:2937–41
  • Becke AD. (1988). Density-functional exchange-energy approximation with correct asymptotic behavior. Phys Rev A 38:3098–100
  • Becke AD. (1993). Density-functional thermochemistry. III. The role of exact exchange. J Chem Phys 98:5648–52
  • Berendsen HJC, Postma JPM, van Gunsteren WF, Hermans J. (1981). Interactions models for water in relation to protein hydration. In: Pullman B, ed. Intermolecular forces. Dordrecht: D. Reidel Publishing, 331–42
  • Bessems JGM, Vermeulen NPE. (2001). Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit Rev Toxicol 31:55–138
  • Brohan J, Donnelly M, Fitzpatrick GJ. (2014). Metabolic acidosis with a raised anion gap associated with high 5-oxoproline levels; an under-recognised cause for metabolic acidosis in intensive care. J Clin Toxicol 4:220
  • Bulera SJ, Birge RB, Cohen SD, Khairallah EA. (1995). Identification of the mouse liver 44-kDa acetaminophen-binding protein as a subunit of glutamine synthetase. Toxicol Appl Pharmacol 134:313–20
  • Chen W, Shockcor JP, Tonge R, et al. (1999). Protein and nonprotein cysteinyl thiol modification by N-acetyl-p-benzoquinone imine via a novel ipso adduct. Biochemistry 38:8159–66
  • Cohen SD, Khairallah EA. (1997). Selective protein arylation and acetaminophen-induced hepatotoxicity. Drug Metab Rev 29:59–77
  • Corbeil CR, Williams CI, Labute P. (2012). Variability in docking success rates due to dataset preparation. J Comput Aided Mol Des 26:775–86
  • Cornell WD, Cieplak P, Bayly CL, et al. (1995). A second generation force fields for the simulation of proteins, nucleic acids, and organic molecules. J Am Chem Soc 117:5179–97
  • Croal BL, Glen ACA, Kelly CJG, Logan RW. (1998). Transient 5-oxoprolinuria (pyroglutamic aciduria) with systemic acidosis in an adult receiving antibiotic therapy. Clin Chem 44:336–40
  • Dahlin DC, Miwa GT, Lu AY, Nelson SD. (1984). N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci USA 81:1327–31
  • De Jesus MC, Ingle BL, Barakat KA, et al. (2014). The role of strong electrostatic interactions at the dimer interface of human glutathione synthetase. Protein J 33:403–9
  • Dietze EC, Schäfer A, Omichinski JG, Nelson SD. (1997). Inactivation of glyceraldehyde-3-phosphate dehydrogenase by a reactive metabolite of acetaminophen and mass spectral characterization of an arylated active site peptide. Chem Res Toxicol 10:1097–103
  • Dinescu A, Anderson ME, Cundari TR. (2007). Catalytic loop motion in human glutathione synthetase: a molecular modeling approach. Biochem Biophys Res Commun 353:450–6
  • Dinescu A, Cundari TR, Bhansali VS, et al. (2004). Function of conserved residues of human glutathione synthetase: implications for the ATP-grasp enzymes. J Biol Chem 279:22412–21
  • Emmett M. (2014). Acetaminophen toxicity and 5-oxoproline (pyroglutamic acid): a tale of two cycles, one an ATP-depleting futile cycle and the other a useful cycle. Clin J Am Soc Nephrol 9:191–200
  • Gali RR, Board PG. (1995). Sequencing and expression of a cDNA for human glutathione synthetase. Biochem J 310:353–8
  • Gali RR, Board PG. (1997). Identification of an essential cysteine residue in human glutathione synthase. Biochem J 321:207–10
  • Geenen S, Guallar-Hoyas C, Michopoulos F, et al. (2011). HPLC-MS/MS methods for the quantitative analysis of 5-oxoproline (pyroglutamate) in rat plasma and hepatic cell line culture medium. J Pharm Biomed Anal 56:655–63
  • Geenen S, du Preez FB, Snoep JL, et al. (2013). Glutathione metabolism modeling: a mechanism for liver drug-robustness and a new biomarker strategy . Biochim Biophys Acta 1830:4943–59
  • Ghauri FYK, McLean AEM, Beales D, et al. (1993). Induction of 5-oxoprolinuria in the rat following chronic feeding with N-acetyl 4-aminophenol (paracetamol). Biochem Pharmacol 46:953–7
  • Gupta S, Rogers LK, Taylor SK, Smith CV. (1997). Inhibition of carbamyl phosphate synthetase-I and glutamine synthetase by hepatotoxic doses of acetaminophen in mice. Toxicol Appl Pharmacol 146:317–27
  • Halmes NC, Hinson JA, Martin BM, Pumford NR. (1996). Glutamate dehydrogenase covalently binds to a reactive metabolite of acetaminophen. Chem Res Toxicol 9:541–6
  • Heard KJ, Green JL, James LP, et al. (2011). Acetaminophen-cysteine adducts during therapeutic dosing and following overdose. BMC Gastroenterol 11:20
  • Hess B, Kutzner C, van der Spoel D, Lindahl E. (2008). GROMACS 4:  algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 4:435–47
  • Hornak V, Abel R, Okur A, et al. (2006). Comparison of multiple amber force fields and development of improved protein backbone parameters. Proteins 65:712–25
  • Jenkins RE, Kitteringham NR, Goldring CEP, et al. (2008). Glutathione-S-transferase pi as a model protein for the characterisation of chemically reactive metabolites. Proteomics 8:301–5
  • Labute P. (2008). The generalized Born/volume integral implicit solvent model: estimation of the free energy of hydration using London dispersion instead of atomic surface area. J Comput Chem 29:1693–8
  • Landin JS, Cohen SD, Khairallah EA. (1996). Identification of a 54-kDa mitochondrial acetaminophen-binding protein as aldehyde dehydrogenase. Toxicol Appl Pharmacol 141:299–307
  • Larsson A, Ristoff E, Anderson ME. (2005). Glutathione synthetase deficiency and other disorders of the γ-glutamyl cycle. In: Valle D, Beaudet AL, Vogelstein, et al., eds. The online metabolic bases of inherited disease. Chapter 96. New York: McGraw-Hill Medical. Available from: http://ommbid.mhmedical.com/content.aspx?sectionid=62677375&bookid=971&jumpsectionID=62677377&Resultclick=2&q=glutathione
  • Liss DB, Paden MS, Schwarz ES, Mullins ME. (2013). What is the clinical significance of 5-oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure? Clin Toxicol (Phila) 51:817–27
  • Luo JL, Huang CS, Babaoglu K, Anderson ME. (2000). Novel kinetics of mammalian glutathione synthetase: characterization of gamma-glutamyl substrate cooperative binding. Biochem Biophys Res Commun 275:577–81
  • Malmezat T, Breuillé D, Capitan P, et al. (2000). Glutathione turnover is increased during the acute phase of sepsis in rats. J Nutr 130:1239–46
  • McConnachie LA, Mohar I, Hudson FN, et al. (2007). Glutamate cysteine ligase modifier subunit deficiency and gender as determinants of acetaminophen-induced hepatotoxicity in mice. Toxicol Sci 99:628–36
  • McGill MR, Lebofsky M, Norris H-RK, et al. (2013). Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose-response, mechanisms, and clinical implications. Toxicol Appl Pharmacol 269:240–9
  • Mehta AN, Emmett JB, Emmett M. (2008). GOLD MARK: an anion gap mnemonic for the 21st century. Lancet 372:892
  • Mitchell JR, Jollow DJ, Potter WZ, et al. (1973). Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 187:211–17
  • Moore M, Thor H, Moore G, et al. (1985). The toxicity of acetaminophen and N-acetyl-p-benzoquinone imine in isolated hepatocytes is associated with thiol depletion and increased cytosolic Ca2+. J Biol Chem 260:13035–40
  • Muldrew KL, James LP, Coop L, et al. (2002). Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using high-performance liquid chromatography with electrochemical detection. Drug Metab Dispos 30:446–51
  • Njålsson R, Carlsson K, Olin B, et al. (2000). Kinetic properties of missense mutations in patients with glutathione synthetase deficiency. Biochem J 349:275–9
  • Njalsson R, Norgren S, Larsson A, et al. (2001). Cooperative binding of gamma-glutamyl substrate to human glutathione synthetase . Biochem Biophys Res Commun 289:80–4
  • Njålsson R, Ristoff E, Carlsson K, et al. (2005). Genotype, enzyme activity, glutathione level, and clinical phenotype in patients with glutathione synthetase deficiency. Hum Genet 116:384–9
  • Oakley AJ, Coggan M, Board PG. (2010). Identification and characterization of gamma-glutamylamine cyclotransferase, an enzyme responsible for gamma-glutamyl-ɛ-lysine catabolism. J Biol Chem 285:9642–8
  • Oppenheimer L, Wellner VP, Griffith OW, Meister A. (1979). Glutathione synthetase. Purification from rat kidney and mapping of the substrate binding sites. J Biol Chem 254:5184–90
  • Orlowski M, Meister A. (1971). Partial reactions catalyzed by glutamylcysteine synthetase and evidence for an activated glutamate intermediate. J Biol Chem 246:7095–105
  • Parkinson E, Boyd P, Aleksic M, et al. (2014). Stable isotope labeling method for the investigation of protein haptenation by electrophilic skin sensitizers. Toxicol Sci 142:239–49
  • Pitt JJ, Hauser S. (1998). Transient 5-oxoprolinuria and high anion gap metabolic acidosis: clinical and biochemical findings in eleven subjects. Clin Chem 44:1497–503
  • Polekhina G, Board PG, Gali RR, et al. (1999). Molecular basis of glutathione synthetase deficiency and a rare gene permutation event. Embo J 18:3204–13
  • Pumford NR, Halmes NC, Martin BM, et al. (1997). Covalent binding of acetaminophen to N-10-formyl-tetrahydrofolate dehydrogenase in mice. J Pharmacol Exp Ther 280:501–5
  • Qiu Y, Benet LZ, Burlingame AL. (1998). Identification of the hepatic protein targets of reactive metabolites of acetaminophen in vivo in mice using two-dimensional gel electrophoresis and mass spectrometry. J Biol Chem 28:17940–53
  • Ristoff E, Larsson A. (2007). Inborn errors in the metabolism of glutathione. Orphanet J Rare Dis 2:16. doi: 10.1186/1750-1172-2-16
  • Shevchenko A, Jensen ON, Podtelejnikov AV, et al. (1996). Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. Proc Natl Acad Sci USA 93:14440–5
  • Slavens KD, Brown TR, Barakat KA, et al. (2011). Valine 44 and valine 45 of human glutathione synthetase are key for subunit stability and negative cooperativity. Biochem Biophys Res Commun 410:597–601
  • Slitt AML, Dominick PK, Roberts JC, Cohen SD. (2005). Effect of ribose cysteine pretreatment on hepatic and renal acetaminophen metabolite formation and glutathione depletion. Basic Clin Pharmacol Toxicol 96:487–94
  • Spielberg SP, Gordon GB. (1981). Glutathione synthetase-deficient lymphocytes and acetaminophen toxicity. Clin Pharmacol Ther 29:51–5
  • Stephens PJ, Devlin FJ, Chabalowski CF, Frisch MJ. (1994). Ab initio calculation of vibrational absorption and circular dichroism spectra using density functional force fields. J Phys Chem 98:11623–7
  • Wang J, Cieplak P, Kollman PA. (2000). How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? J Comput Chem 21:1049–74
  • Williamson JM, Meister A. (1982). Effect of sulfhydryl group modification on the activities of 5-oxo-L-prolinase. J Biol Chem 257:9161–72
  • Wu G, Fang Y-Z, Yang S, et al. (2004). Glutathione metabolism and its implications for health. J Nutr 134:489–92

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.